(VIANEWS) – Ameresco (AMRC), Range Resources Corporation (RRC), Catalyst Pharmaceuticals (CPRX) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Ameresco (AMRC)
32.9% sales growth and 5.86% return on equity
Ameresco, Inc. provides comprehensive energy services for businesses and organizations in North America and Europe. It offers energy efficiency, infrastructure upgrades, energy security and resilience, asset sustainability, and renewable energy solutions. The company operates through U.S. Regions, U.S. Federal, Canada, and Non-Solar Distributed Generation segments. It designs, develops, engineers, and installs projects that reduce the energy, as well as operations and maintenance costs of customers' facilities. The company's projects primarily include various measures customized for the facility and designed to enhance the efficiency of building systems, such as heating, ventilation, cooling, and lighting systems. It also offers renewable energy products and services, such as the construction of small-scale plants for customers that produce electricity, gas, heat, or cooling from renewable sources of energy; and sells electricity and processed renewable gas fuel, heat, or cooling. In addition, the company provides integrated- photovoltaic (PV) and consulting, and enterprise energy management services; sells solar PV energy products and systems; and owns and operates a wind power project located in County Kerry, Ireland. It serves federal, state, and local governments, as well as healthcare and educational institutions, housing authorities, and commercial and industrial customers. As of December 31, 2019, the company owned and operated 99 small-scale renewable energy plants and solar PV installations. Ameresco, Inc. was founded in 2000 and is headquartered in Framingham, Massachusetts.
Earnings Per Share
As for profitability, Ameresco has a trailing twelve months EPS of $1.09.
PE Ratio
Ameresco has a trailing twelve months price to earnings ratio of 29.26. Meaning, the purchaser of the share is investing $29.26 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.86%.
Sales Growth
Ameresco’s sales growth is 15.8% for the current quarter and 32.9% for the next.
Moving Average
Ameresco’s worth is higher than its 50-day moving average of $31.50 and way higher than its 200-day moving average of $26.68.
Volume
Today’s last reported volume for Ameresco is 271671 which is 46.18% below its average volume of 504792.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.1%, now sitting on 1.4B for the twelve trailing months.
2. Range Resources Corporation (RRC)
23.9% sales growth and 13.51% return on equity
Range Resources Corporation operates as an independent natural gas, natural gas liquids (NGLs), crude oil, and condensate company in the United States. The company engages in the exploration, development, and acquisition of natural gas and crude oil properties located in the Appalachian region. It sells natural gas to utilities, marketing and midstream companies, and industrial users; NGLs to petrochemical end users, marketers/traders, and natural gas processors; and oil and condensate to crude oil processors, transporters, and refining and marketing companies. The company was formerly known as Lomak Petroleum Inc. and changed its name to Range Resources Corporation in August 1998. Range Resources Corporation was founded in 1976 and is headquartered in Fort Worth, Texas.
Earnings Per Share
As for profitability, Range Resources Corporation has a trailing twelve months EPS of $2.
PE Ratio
Range Resources Corporation has a trailing twelve months price to earnings ratio of 16.58. Meaning, the purchaser of the share is investing $16.58 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.51%.
3. Catalyst Pharmaceuticals (CPRX)
20.4% sales growth and 14.55% return on equity
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was founded in 2002 and is based in Coral Gables, Florida.
Earnings Per Share
As for profitability, Catalyst Pharmaceuticals has a trailing twelve months EPS of $0.63.
PE Ratio
Catalyst Pharmaceuticals has a trailing twelve months price to earnings ratio of 24.16. Meaning, the purchaser of the share is investing $24.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.55%.
Moving Average
Catalyst Pharmaceuticals’s worth is below its 50-day moving average of $16.05 and above its 200-day moving average of $15.00.
Volume
Today’s last reported volume for Catalyst Pharmaceuticals is 817840 which is 36.47% below its average volume of 1287390.
Sales Growth
Catalyst Pharmaceuticals’s sales growth for the next quarter is 20.4%.
Yearly Top and Bottom Value
Catalyst Pharmaceuticals’s stock is valued at $15.22 at 20:22 EST, way under its 52-week high of $17.99 and way higher than its 52-week low of $11.55.
4. Ternium S.A. Ternium S.A. (TX)
18.2% sales growth and 6.28% return on equity
Ternium S.A., together with its subsidiaries, manufactures and distributes steel products in Mexico, Southern Region, Brazil, and internationally. It operates through three segments: Steel, Mining, and Usiminas. The Steel segment offers slabs, hot and cold rolled products, coated products, roll formed and tubular products, bars, billets, and other products. Its Mining segment sells iron ore and pellets. The Usiminas segment offers iron ore extraction, steel transformation, and production of capital goods and logistics; and manufactures and sells various products and raw materials, such as flat steel, iron ore, and stamped steel parts for the automotive industry and products for the civil construction and capital goods industry. It also provides medical and social; scrap; renewable energy; and engineering and other services, as well as operates as a distribution company. In addition, the company engages in the exploration, exploitation, and pelletizing of iron ore. Ternium S.A. was founded in 1961 and is based in Luxembourg City, Luxembourg. Ternium S.A. is a subsidiary of Techint Holdings S.à r.l.
Earnings Per Share
As for profitability, Ternium S.A. Ternium S.A. has a trailing twelve months EPS of $3.3.
PE Ratio
Ternium S.A. Ternium S.A. has a trailing twelve months price to earnings ratio of 10.87. Meaning, the purchaser of the share is investing $10.87 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.28%.
Volume
Today’s last reported volume for Ternium S.A. Ternium S.A. is 144528 which is 42.94% below its average volume of 253300.
Sales Growth
Ternium S.A. Ternium S.A.’s sales growth is 18.2% for the current quarter and 18.2% for the next.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 60.8% and positive 133.7% for the next.
5. Fabrinet Ordinary Shares (FN)
13.7% sales growth and 17.79% return on equity
Fabrinet provides optical packaging and precision optical, electro-mechanical, and electronic manufacturing services in North America, the Asia-Pacific, and Europe. The company offers a range of advanced optical and electro-mechanical capabilities in the manufacturing process, including process design and engineering, supply chain management, manufacturing, printed circuit board assembly, advanced packaging, integration, final assembly, and testing. Its products include switching products, including reconfigurable optical add-drop multiplexers, optical amplifiers, modulators, and other optical components and modules that enable network managers to route voice, video, and data communications traffic through fiber optic cables at various wavelengths, speeds, and over various distances. The company's products also comprise tunable lasers, transceivers, and transponders; and active optical cables, which provide high-speed interconnect capabilities for data centers and computing clusters, as well as Infiniband, Ethernet, fiber channel, and optical backplane connectivity. In addition, it provides solid state, diode-pumped, gas, and fiber lasers used in semiconductor processing, biotechnology and medical device, metrology, and material processing industries; and differential pressure, micro-gyro, fuel, and other sensors used in automobiles, as well as non-contact temperature measurement sensors for the medical industry. Further, the company designs and fabricates application-specific crystals, lenses, prisms, mirrors, laser components, and substrates; and other custom and standard borosilicate, clear fused quartz, and synthetic fused silica glass products. It serves original equipment manufacturers of optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices, and sensors. The company was incorporated in 1999 and is based in George Town, the Cayman Islands.
Earnings Per Share
As for profitability, Fabrinet Ordinary Shares has a trailing twelve months EPS of $7.54.
PE Ratio
Fabrinet Ordinary Shares has a trailing twelve months price to earnings ratio of 31.33. Meaning, the purchaser of the share is investing $31.33 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.79%.
6. Crane Company (CR)
10.3% sales growth and 12.42% return on equity
Crane Co. manufactures and sells engineered industrial products in the United States, Canada, the United Kingdom, Continental Europe, and internationally. The company's Fluid Handling segment offers on/off valves and related products for the chemical, oil and gas, power, and general industrial end markets; valves and related products for the non-residential construction, general industrial, and municipal markets; fluid control instrumentation and sampling solutions; and pumps and related products for water and wastewater applications in industrial, municipal, commercial, and military markets. This segment sells its products under the Crane, Saunders, Jenkins, Pacific, Xomox, Krombach, DEPA, ELRO, REVO, Flowseal, Centerline, Resistoflex, Duochek, Barksdale, Westlock, WTA, HOKE, DOPAK, Stockham, Wask, Viking Johnson, IAT, Hattersley, NABIC, Sperryn, Wade, Deming, Weinman, Burks, and Barnes brands. Its Payment & Merchandising Technologies segment provides technology payment acceptance and dispensing products to original equipment manufacturers and for vertical markets; currency handling and processing systems, cash and cashless payment and merchandising solutions, equipment service solutions, and connected managed service solutions. The company's Aerospace & Electronics segment offers original equipment and aftermarket parts under the Hydro-Aire, ELDEC, Lear Romec, P.L. Porter, Keltec, Interpoint, Signal Technology, Merrimac Industries, and Polyflon brands to commercial and military aerospace, and defense and space markets. Its Engineered Materials segment provides fiberglass-reinforced plastic panels and coils primarily for use in the manufacturing of recreational vehicles, truck bodies, and trailers, as well as used in commercial and industrial building construction. Crane Co. was founded in 1855 and is based in Stamford, Connecticut.
Earnings Per Share
As for profitability, Crane Company has a trailing twelve months EPS of $3.68.
PE Ratio
Crane Company has a trailing twelve months price to earnings ratio of 41. Meaning, the purchaser of the share is investing $41 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.42%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10%, now sitting on 2.14B for the twelve trailing months.
Moving Average
Crane Company’s worth is above its 50-day moving average of $145.37 and way above its 200-day moving average of $123.77.
Sales Growth
Crane Company’s sales growth is 11.5% for the present quarter and 10.3% for the next.
